Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-09-18

Clinical Trial Update: Evaluation of Efficacy of Mesalamine in the Long-term Prevention of Diverticulitis Flares [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the long-term prevention of diverticulitis flares with mesalamine has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesalamine (Mesalamine)

Snippet

Sponsor: SOFAR S.p.A. | Conditions: Diverticular Disease | Phase 3 | Status: COMPLETED